Engineered DNA Deaminases for Methylation Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for identifying modified cytosines in DNA require a denaturation step, which is undesirable, and existing deaminases are limited in their ability to act on double-stranded DNA substrates without denaturing them.

Innovation Solution

Development of double-stranded DNA deaminases that can deaminate cytosines in both double-stranded and single-stranded DNA substrates without denaturing the DNA, allowing for the identification of modified cytosines such as 5mC and 5hmC without the need for denaturation steps, using enzymes like TET methylcytosine dioxygenase and DNA beta-glucosyltransferase to modify substrates and enhance specificity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If current deaminase methods are used to identify modified cytosines, then cytosine deamination can be achieved, but a denaturation step is required which complicates the workflow

Engineering Contradiction:
Improveworkflow simplicityVSAvoiddenaturation step requirement
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The patent changes the substrate binding parameters of deaminases through protein engineering, enabling them to recognize and bind to double-stranded DNA structures that natural deaminases cannot process. This allows deamination to occur on dsDNA without requiring denaturation, eliminating the extra workflow step while maintaining deamination functionality

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The engineered deaminases gain the ability to process both double-stranded and single-stranded DNA substrates, making them universally applicable to different DNA forms. This multi-functionality eliminates the need for separate denaturation and deamination steps, simplifying the overall workflow for identifying modified cytosines

Inventive Principle:
Principle #6Universality (Multi-functionality)

2Adaptability or versatility

If existing deaminases are used, then cytosine deamination is possible, but they cannot act on double-stranded DNA without denaturing it

Engineering Contradiction:
Improvesubstrate type flexibilityVSAvoiddsDNA deamination capability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent modifies key parameters of deaminase proteins including their substrate binding pockets and structural conformations to enable recognition of double-stranded DNA. This allows the enzymes to reliably process dsDNA substrates that were previously inaccessible, expanding substrate type flexibility while maintaining deamination reliability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent introduces intermediary structural elements or modifications to the deaminase proteins that facilitate their interaction with double-stranded DNA. These intermediaries act as mediators between the enzyme and the dsDNA substrate, enabling the enzyme to access and process cytosines in the context of double-stranded DNA without requiring denaturation

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If denaturation step is included in the workflow, then modified cytosines can be identified, but the workflow complexity increases

Engineering Contradiction:
Improvemodified cytosine identification accuracyVSAvoidworkflow steps
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts and eliminates the denaturation step from the workflow by engineering deaminases that can directly process double-stranded DNA. This removal of the unnecessary intermediate step simplifies the workflow while preserving the ability to accurately identify modified cytosines through deamination and sequencing

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent enables continuous deamination action on double-stranded DNA without interruption for denaturation. The engineered deaminases can process dsDNA substrates continuously, maintaining measurement precision for modified cytosine identification while reducing workflow complexity by eliminating the break in the process

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables efficient identification of modified cytosines in DNA without denaturing the DNA, simplifying workflows and improving the accuracy of methylation analysis by allowing sequencing of double-stranded DNA substrates, reducing the complexity of current methods and enhancing the detection of methylation profiles.

Implementation Method 1

cytosine deaminases that are active on DNA substrates... deaminate cytosines in a double-stranded DNA substrate

Methodology Applied
Scientific EffectDeamination: Hydrolysis

Implementation Method 2

one or more enzymes that alter the deamination susceptibility of one or more modified cytosines (e.g., a TET methylcytosine dioxygenase)

Methodology Applied
Scientific EffectOxygenation: Oxidation

Implementation Method 3

a TET methylcytosine dioxygenase and/or a DNA beta-glucosyltransferase

Methodology Applied
Scientific EffectGlycosylation:

Data Source

PatentUS20230357838A1Double-Stranded DNA Deaminases and Uses Thereof
Publication Date: 2023.11.09 NEW ENGLAND BIOLABS INC
  • US20230357838A1 patent drawing
  • US20230357838A1 patent drawing
  • US20230357838A1 patent drawing

AI summary

Provided herein, among other things, is a method for deaminating a double-stranded nucleic acid. In some embodiments, the method may comprise contacting a double-stranded DNA substrate that comprises cytosines and a double-stranded DNA deaminase having an amino acid sequence that is at least 80% identical to any of SEQ ID NOS: 21, 40, 47, 49, 50, 55, 58, 59, 62, 63, 65, 67, 70, 71, 76, 106, 107, 110, 112, 114, 117, 163 and/or 164 to produce a deamination product that comprises deaminated cytosines. Enzymes and kits for performing the method are also provided.